Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1α via the PI3K/Akt/ERK pathway

[1]  Abolfazl Kasaee,et al.  Clinical and Ultrasonographic Evaluation of Infantile Periocular Hemangioma Treated With Oral Propranolol. , 2019, Ophthalmic plastic and reconstructive surgery.

[2]  T. Kurihara,et al.  Pharmacological HIF inhibition prevents retinal neovascularization with improved visual function in a murine oxygen-induced retinopathy model , 2019, Neurochemistry International.

[3]  Fangfang Hu,et al.  Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway. , 2019, Gene.

[4]  Dongdong Jiang,et al.  Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression , 2019, Anti-cancer drugs.

[5]  G. Ying,et al.  Perinatal Risk Factors for the Retinopathy of Prematurity in Postnatal Growth and Rop Study , 2019, Ophthalmic epidemiology.

[6]  G. Mills,et al.  Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. , 2019, The Lancet. Oncology.

[7]  Qi Wang,et al.  Netrin‑1 interference potentiates epithelial‑to‑mesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of non‑small cell lung cancer. , 2019, International journal of oncology.

[8]  S. Oltean,et al.  Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis , 2019, Cells.

[9]  Asami Osada,et al.  Combination therapy of propranolol, levothyroxine, and liothyronine was effective in a case of severe consumptive hypothyroidism associated with infantile hepatic hemangioma , 2019, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[10]  A. Mercurio.  VEGF/Neuropilin Signaling in Cancer Stem Cells , 2019, International journal of molecular sciences.

[11]  K. Aggarwal,et al.  Change in the incidence and severity of Retinopathy of Prematurity (ROP) in a Neonatal Intensive Care Unit in Northern India after 20 years: Comparison of two similar prospective cohort studies , 2019, Ophthalmic epidemiology.

[12]  Haishan Lin,et al.  VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes , 2018, Journal of Cancer.

[13]  C. Cho,et al.  Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy. , 2018, Biochemical and biophysical research communications.

[14]  Lei Zhang,et al.  VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis , 2018, PloS one.

[15]  L. Yao,et al.  PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia , 2018, Molecular medicine reports.

[16]  P. Bagnoli,et al.  The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy , 2017, Front. Cell. Neurosci..

[17]  P. Bagnoli,et al.  Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen‐induced retinopathy: beneficial effect of the absence of AQP4 , 2017, Journal of cellular and molecular medicine.

[18]  Lois E. H. Smith,et al.  Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis , 2017, Nature Communications.

[19]  G. Buonocore,et al.  Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial , 2017, BMC Pediatrics.

[20]  A. L. Solebo,et al.  Epidemiology of blindness in children , 2017, Archives of Disease in Childhood.

[21]  Changwei Li,et al.  PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy , 2017, Scientific Reports.

[22]  Haibo Wang.  Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy , 2016, Eye and Brain.

[23]  G. Lutty,et al.  Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity , 2016, Eye and brain.

[24]  S. Loo,et al.  Retinopathy of Prematurity and Ethnicity in Hawai'i: A Retrospective Study (1996 - 2006) of Medical Records from Kapi'olani Medical Center for Women and Children. , 2016, Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health.

[25]  Zixin Yang,et al.  [Effects of propranolol on oxygen-induced retinal neovascularization in mouse]. , 2016, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[26]  Xiao-long Chen,et al.  CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy , 2015, International journal of molecular medicine.

[27]  Xiao-long Chen,et al.  The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt–VEGF signaling pathway , 2015, Drug design, development and therapy.

[28]  Qiutang Li,et al.  PTB-associated splicing factor inhibits IGF-1-induced VEGF upregulation in a mouse model of oxygen-induced retinopathy , 2015, Cell and Tissue Research.

[29]  J. Li,et al.  Incidence of Retinopathy of Prematurity in Southwestern China and Analysis of Risk Factors , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[30]  S. Furlanetto,et al.  Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. , 2013, The Journal of pediatrics.

[31]  A. Fielder,et al.  Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010 , 2013, Pediatric Research.

[32]  P. Bagnoli,et al.  Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice. , 2013, Experimental eye research.

[33]  F. Biagioni,et al.  Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats , 2012, Brain Research.

[34]  A. Fernandez-cruz,et al.  Circulating endothelial progenitor cells are reduced in rat oxygen-induced retinopathy despite a retinal SDF-1/CXCR4 and VEGF proangiogenic response. , 2012, Life sciences.

[35]  Lois E. H. Smith,et al.  Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. , 2012, Investigative ophthalmology & visual science.

[36]  Xiao-feng Tian,et al.  Protein Kinase B (Akt) Promotes Pathological Angiogenesis in Murine Model of Oxygen-Induced Retinopathy , 2011, Acta histochemica et cytochemica.

[37]  P. Fortunato,et al.  Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. , 2011, Investigative ophthalmology & visual science.

[38]  Darius M Moshfeghi,et al.  Incidence of retinopathy of prematurity in the United States: 1997 through 2005. , 2009, American journal of ophthalmology.

[39]  C. Gilbert.  Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. , 2008, Early human development.

[40]  B. Jiang,et al.  AKT signaling in regulating angiogenesis. , 2008, Current cancer drug targets.

[41]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[42]  D. Coats,et al.  Prevalence and Course of Strabismus in the First Year of Life for Infants With Prethreshold Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study , 2006 .

[43]  William V Good,et al.  The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study , 2005, Pediatrics.

[44]  H. Mahdy,et al.  Risk Factors of Retinopathy of Prematurity , 2002, Foreign Language Science and Technology Journal Database Medicine and Health.

[45]  L. Ellis,et al.  Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells* , 2002, The Journal of Biological Chemistry.

[46]  P. Chandraratna.  Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials. , 1985, American heart journal.

[47]  B. Widgren,et al.  [A 10-year follow-up of men with mild hypertension. Bendroflumethiazide and propranolol give equal effect in treatment of high blood pressure]. , 1985, Lakartidningen.

[48]  J. Drayer,et al.  The Combined Alpha‐ and Beta‐Adrenergic Blocker Labetalol and Propranolol in the Treatment of High Blood Pressure: Similarities and Differences , 1984, Journal of clinical pharmacology.

[49]  S. Ferrari,et al.  Author contributions , 2021 .

[50]  J. Stockman.  The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study , 2007 .

[51]  Gudrun Wacker.  Similarities and Differences , 2005 .

[52]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[53]  C. Furberg,et al.  Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. , 1986, Journal of the American College of Cardiology.